Skip to main content
  • Investors
  • Mediaopen in a new window
  • Contact Usopen in a new window
  • |
Ironwood Logoopen in a new window
  • Company
  • Science & Medicine
  • Patients
  • Responsibility
  • Careers
  • IR Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Investor FAQs
  • Press Releases
  • Investor Contacts
    • Investor Emails Alerts
    • RSS Feeds
  • IR Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Investor FAQs
  • Press Releases
  • Investor Contacts
    • Investor Emails Alerts
    • RSS Feeds
Close
Close
  • Investors
  • Company
  • Product
  • Research & Development
  • Patients
  • Partnerships
  • Careers
Close

Press Releases

Normal
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
December 22, 2016
Ironwood and Allergan Report Topline Phase IIb Data Supporting Further Investigation of Linaclotide Colonic Release-2 (CR2) for Abdominal Pain in Non-Constipation Subtypes of IBS
Download PDF format download (opens in new window)
December 22, 2016
Ironwood and Allergan Report Topline Phase IIb Data Supporting Advancement of Linaclotide Colonic Release-1 (CR1) in IBS-C
Download PDF format download (opens in new window)
December 19, 2016
Ironwood Pharmaceuticals Announces Approval of LINZESS® (linaclotide) in Japan for the Treatment of Adults with IBS-C
Download PDF format download (opens in new window)
November 13, 2016
Ironwood Highlights ZURAMPIC® (lesinurad) Phase III Extension Study Data at the American College of Rheumatology 2016 Annual Meeting
Download PDF format download (opens in new window)
November 10, 2016
Ironwood Pharmaceuticals to Present at Stifel 2016 Healthcare Conference
Download PDF format download (opens in new window)
November 3, 2016
Ironwood Pharmaceuticals Provides Third Quarter 2016 Investor Update
Download PDF format download (opens in new window)
November 1, 2016
Ironwood Pharmaceuticals to Present at Credit Suisse 25th Annual Healthcare Conference
Download PDF format download (opens in new window)
October 25, 2016
Ironwood Highlights Breadth of Gout Research with Presentations at the American College of Rheumatology 2016 Annual Meeting
Download PDF format download (opens in new window)
October 20, 2016
Ironwood Pharmaceuticals to Host Third Quarter 2016 Investor Update Call
Download PDF format download (opens in new window)
October 3, 2016
Nine in Ten Physicians Agree Target Goal for Gout Is Imperative, Yet Half of Patients Fail to Reach It, New Survey Shows
Download PDF format download (opens in new window)
October 3, 2016
Ironwood Announces U.S. Availability of ZURAMPIC® (lesinurad) 200 mg Tablets for Patients with Uncontrolled Gout
Download PDF format download (opens in new window)
September 26, 2016
Ironwood Closes $150 Million Debt Refinancing
Download PDF format download (opens in new window)
September 7, 2016
Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Download PDF format download (opens in new window)
September 1, 2016
Ironwood Pharmaceuticals to Present at Wells Fargo 2016 Healthcare Conference
Download PDF format download (opens in new window)
August 4, 2016
Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update
Download PDF format download (opens in new window)
July 21, 2016
Ironwood Pharmaceuticals to Host Second Quarter 2016 Investor Update Call
Download PDF format download (opens in new window)
June 9, 2016
Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review
Download PDF format download (opens in new window)
June 6, 2016
Ironwood Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference
Download PDF format download (opens in new window)
June 3, 2016
Ironwood Pharmaceuticals Closes U.S. Transaction with AstraZeneca for Lesinurad
Download PDF format download (opens in new window)
June 1, 2016
Ironwood Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference
Download PDF format download (opens in new window)
May 18, 2016
Ironwood Pharmaceuticals to Present at 2016 UBS Global Healthcare Conference
Download PDF format download (opens in new window)
May 17, 2016
Ironwood Pharmaceuticals to Present Linaclotide Data at Digestive Disease Week® 2016
Download PDF format download (opens in new window)
May 9, 2016
Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update
Download PDF format download (opens in new window)
May 3, 2016
Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2016 Health Care Conference
Download PDF format download (opens in new window)
April 26, 2016
Ironwood Pharmaceuticals Enters into U.S. Licensing Agreement with AstraZeneca for Lesinurad
Download PDF format download (opens in new window)
April 25, 2016
Ironwood Pharmaceuticals to Host First Quarter 2016 Investor Update Call
Download PDF format download (opens in new window)
April 7, 2016
Ironwood Pharmaceuticals Appoints Andrew Dreyfus to Board of Directors
Download PDF format download (opens in new window)
April 5, 2016
Ironwood Pharmaceuticals Reports Top-Line Data from Exploratory Phase IIa Study of IW-9179 in Diabetic Gastroparesis
Download PDF format download (opens in new window)
March 30, 2016
Ironwood Pharmaceuticals to Present Clinical and Preclinical Data on sGC Stimulators at Upcoming Scientific Conferences
Download PDF format download (opens in new window)
March 23, 2016
Ironwood Pharmaceuticals Initiates Phase IIb Clinical Trial of IW-3718 in Refractory Gastroesophageal Reflux Disease
Download PDF format download (opens in new window)
March 9, 2016
Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Download PDF format download (opens in new window)
March 1, 2016
Ironwood Pharmaceuticals to Present at Cowen and Company 36th Annual Health Care Conference
Download PDF format download (opens in new window)
February 29, 2016
Video Alert: Updated 2016 Direct-to-Consumer Awareness Campaign Available for LINZESS® (linaclotide)
Download PDF format download (opens in new window)
February 24, 2016
Ironwood Pharmaceuticals Announces Filing by Astellas of New Drug Application in Japan with Linaclotide for the Treatment of Adults with IBS-C
Download PDF format download (opens in new window)
February 18, 2016
Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2015 Investor Update
Download PDF format download (opens in new window)
February 18, 2016
Ironwood Pharmaceuticals Progresses Vascular and Fibrotic Disease Platform with Positive Top-Line Phase Ia Data on Soluble Guanylate Cyclase Stimulator IW-1701
Download PDF format download (opens in new window)
February 17, 2016
Ironwood Pharmaceuticals to Present at 2016 RBC Capital Markets Global Healthcare Conference
Download PDF format download (opens in new window)
February 4, 2016
Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2015 Investor Update Call
Download PDF format download (opens in new window)
January 11, 2016
Ironwood Pharmaceuticals Details Strategy to Build Top-Performing Commercial Biotechnology Company
Download PDF format download (opens in new window)
January 4, 2016
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Download PDF format download (opens in new window)

Investor Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Ironwood Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates.

* Required

*
*





Email Alert Sign Up Confirmation

Ironwood Logoopen in a new window
  • Investors
  • Media
  • Contact us
Follow us on Linkedin Follow us on Twitter

COMPANY

  • Company Overview
  • Leadership
  • Open Payments & Transparecy

PRODUCT

  • Linzees

RESEARCH & DEVELOPMENT

  • Pipeline
  • Medical Affairs

PARTNERSHIPS

  • Overview
  • Grants

PATIENTS

  • Overview

RESPONSBILITY

  • Overview
  • Community Giving
  • Equity,Diversity & Inclusion
  • Sustainability
  • Safety & Compliance
  • Patients & Research

CAREERS

  • Working at Ironwood
  • Open Positions
  • Internships, Co-ops & Fellowships

INVESTORS

  • Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
  • Finanical Information
  • Investor FAQ
  • Press Releases
  • Investor Contacts
  • Copyright © Ironwood. All rights reserved Powered By Q4 Inc. 5.77.0.2 (opens in new window)
  • Privacy Policy
  • California Privacy Policy
  • Site Map
  • Terms of Use